Govindan R - Search Results

1

Phase Ib/II study of the pan-cyclin-dependent kinase inhibitor roniciclib in combination with chemotherapy in patients with extensive-disease small-cell lung cancer.

Cho BC, Dy GK, Govindan R, Kim DW, Pennell NA, Zalcman G, Besse B, Kim JH, Koca G, Rajagopalan P, Langer S, Ocker M, Nogai H, Barlesi F. Cho BC, et al. Among authors: govindan r. Lung Cancer. 2018 Sep;123:14-21. doi: 10.1016/j.lungcan.2018.04.022. Epub 2018 Apr 27. Lung Cancer. 2018. PMID: 30089585 Free article. Clinical Trial.

2

Practical issues in the management of the patient with small cell lung cancer.

Govindan R, Ihde DC. Govindan R, et al. Chest Surg Clin N Am. 1997 Feb;7(1):167-81. Chest Surg Clin N Am. 1997. PMID: 9001763 Review.

3

Phase II evaluation of amifostine as an esophageal mucosal protectant in the treatment of limited-stage small cell lung cancer with chemotherapy and twice-daily radiation.

Arquette M, Wasserman T, Govindan R, Garfield D, Senzer N, Gillenwater H, Socinski M. Arquette M, et al. Among authors: govindan r. Semin Radiat Oncol. 2002 Jan;12(1 Suppl 1):59-61. doi: 10.1053/srao.2002.31375. Semin Radiat Oncol. 2002. PMID: 11917286 Clinical Trial.

4

Phase I dose and sequencing study of pegylated liposomal doxorubicin and docetaxel in patients with advanced malignancies.

Fracasso PM, Rodriguez LC, Herzog TJ, Fears CL, Goodner SA, Govindan R, Picus J, Rader JS, Tan BR, Arquette MA. Fracasso PM, et al. Among authors: govindan r. Cancer. 2003 Aug 1;98(3):610-7. doi: 10.1002/cncr.11547. Cancer. 2003. PMID: 12879480 Free article. Clinical Trial.

5

Irinotecan and carboplatin in metastatic or recurrent non-small-cell lung cancer.

Govindan R, Read W, Faust J, Mc Leod H. Govindan R, et al. Oncology (Williston Park). 2003 Jul;17(7 Suppl 7):27-9. Oncology (Williston Park). 2003. PMID: 12886871 Clinical Trial.

6

Phase II study of docetaxel and irinotecan in metastatic or recurrent esophageal cancer: a preliminary report.

Govindan R, Read W, Faust J, Trinkaus K, Ma MK, Baker SD, McLeod HL, Perry MC. Govindan R, et al. Oncology (Williston Park). 2003 Sep;17(9 Suppl 8):27-31. Oncology (Williston Park). 2003. PMID: 14569845 Free article. Clinical Trial.

7

Cetuximab in advanced non-small cell lung cancer.

Govindan R. Govindan R. Clin Cancer Res. 2004 Jun 15;10(12 Pt 2):4241s-4244s. doi: 10.1158/1078-0432.CCR-040015. Clin Cancer Res. 2004. PMID: 15217966 Review.

8

Single agent gefitinib as first line therapy in patients with advanced non-small cell lung cancer: Washington University experience.

Kommareddy A, Coplin MA, Gao F, Behnken D, Romvari E, Read W, Govindan R. Kommareddy A, et al. Among authors: govindan r. Lung Cancer. 2004 Aug;45(2):221-5. doi: 10.1016/j.lungcan.2004.01.022. Lung Cancer. 2004. PMID: 15246194

9

Treatment approaches in patients with advanced non-small cell lung cancer and poor performance status.

Govindan R, Garfield DH. Govindan R, et al. Semin Oncol. 2004 Dec;31(6 Suppl 11):27-31. doi: 10.1053/j.seminoncol.2004.10.006. Semin Oncol. 2004. PMID: 15599832 Review.

10

Lack of trastuzumab activity in nonsmall cell lung carcinoma with overexpression of erb-B2: 39810: a phase II trial of Cancer and Leukemia Group B.

Clamon G, Herndon J, Kern J, Govindan R, Garst J, Watson D, Green M; Cancer and Leukemia Group B. Clamon G, et al. Among authors: govindan r. Cancer. 2005 Apr 15;103(8):1670-5. doi: 10.1002/cncr.20950. Cancer. 2005. PMID: 15751020 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

656 results

Search Page

Filters